Name: Julia Strandberg
New title: Chief business leader of Connected Care
Previous title: Chief commercial officer, Pear Therapeutics
Julia Strandberg will lead Philips’ Connected Care business, a position formerly held by Roy Jakobs before he became CEO of the company in October. The segment, which includes Philips’ sleep and respiratory care, patient monitoring and informatics products, reported $4.4 billion in revenue in 2022, an 11% year-over-year decrease in comparable sales growth.
Philips is still in the midst of a recall of 5.5 million sleep apnea and ventilator devices that started in June 2021. Earlier this year, the company announced a restructuring that involved cutting 10,000 roles, among other moves to reduce costs, with the Respironics unit bearing the brunt of the changes.
Strandberg will start the new role on April 24, succeeding Dan Leonard, who served as interim business leader after Jakobs became CEO.
“Julia brings deep, multi-disciplinary expertise, including in informatics and monitoring, to Philips,” Jakobs said in a statement. “Passionate about improving the healthcare experience for patients and providers across care settings, Julia understands how to deliver in the global healthcare ecosystem and adds extensive experience in developing and commercializing medical technologies.”
Currently, Strandberg serves as chief commercial officer for Pear Therapeutics, a Boston-based company making digital therapeutics to treat substance use disorder and insomnia. She also has led a healthcare consulting firm and previously led Medtronic’s global Health Informatics and Monitoring business.
